Vaginitis Diagnostics Market to reach USD 4.1 billion in 2031, expanding at a CAGR of 9.5%: TMR Report
August 08, 2023 08:15 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The global vaginitis diagnostics market is projected to flourish at a CAGR of 9.5% from 2022 to 2031. As per the report...
Solas BioVentures Co-Founder David Adair, M.D. Joins Mayfield Pharmaceuticals Board of Directors
October 23, 2019 07:30 ET
|
Harrow Health, Inc.
BOSTON, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced David Adair, M.D. will join the...
Mayfield Pharmaceuticals to Present at the SVB Leerink New Treatments Focused on Women’s Health Conference on October 10, 2019
October 08, 2019 07:35 ET
|
Harrow Health, Inc.
BOSTON, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its Chief Executive Officer, Melissa...
Harrow Health Announces Launch of Mayfield Pharmaceuticals
July 31, 2019 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., July 31, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), today announced it has filed a Form 8-K with the Securities and Exchange Commission containing a corporate...
Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial Vaginosis
January 18, 2018 07:00 ET
|
Melinta Therapeutics
NEW HAVEN, Conn., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial...